Frank Pallone actually said...

To assist, Congress reauthorized GDUFA, which allowed FDA to collect generic drug user fees, which could then be used to hire additional ins...

So in addition to taking action against those firms, FDA also issued a warning letter to Dollar Tree...

Despite this, FDA's foreign drug inspection program continues to be challenged by the same longstanding issues that have persisted for years...

As has been mentioned today, this committee has been examining FDA's foreign drug inspection program for nearly two decades.